Rachel Greatwood, DO
Family Medicine · Mesa, AZNPI 1912431800
Payments from drug & device makers
Across 235 payments — averaging $6332.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$564K
- AstraZeneca$267K
- GSK$228K
- Eli Lilly$205K
- Modernatx, Inc.$102K
- Sanofi US Services Inc.$84K
- plus $37K from 29 others
Across 2 payments — averaging $611.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 42 | $564,346 |
| AstraZeneca | 10 | $267,059 |
| GSK | 45 | $228,081 |
| Eli Lilly | 7 | $205,185 |
| Modernatx, Inc. | 31 | $101,872 |
| Sanofi US Services Inc. | 4 | $84,419 |
| Sekisui Diagnostics LLC | 1 | $35,375 |
| AbbVie | 24 | $400 |
| Boston Scientific | 5 | $194 |
| Abbott | 6 | $167 |
| Amgen(2 entities) | 6 | $114 |
| Otsuka America Pharmaceutical, Inc. | 6 | $104 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $95 |
| Sanofi-aventis U.S. LLC | 6 | $93 |
| Astellas Pharma US Inc | 4 | $88 |
| Novo Nordisk | 3 | $61 |
| Boehringer Ingelheim | 3 | $51 |
| Optos, Inc. | 2 | $48 |
| Biohaven Pharmaceuticals, Inc. | 2 | $47 |
| Baxter Healthcare | 1 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $42 |
| Bayer | 2 | $34 |
| Johnson & Johnson | 2 | $34 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| Dexcom, Inc. | 2 | $31 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Novartis | 1 | $19 |
| Impel Pharmaceuticals Inc. | 1 | $18 |
| Actelion Pharmaceuticals US, Inc. | 1 | $18 |
| Intra-sana Laboratories | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Alfasigma USA, Inc. | 1 | $16 |
| Lexicon Pharmaceuticals, Inc. | 1 | $16 |
| Itamar Medical Inc | 1 | $15 |
| Axonics, Inc. | 1 | $14 |
How this compares
$1,488,187 in reported general payments places this provider in the 95th percentile of 2,099 family medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Mesa
- Terry O'ReillyMesa$35.8M
- Corey AndersonMesa$21.5M
- Gerald ShockeyMesa$12.3M
- Donna DesantisMesa$776K
- Yadwinder DhillonMesa$445K
- Benjamin ClarkMesa$441K
- Suzanne BentzMesa$174K
- William ReedyMesa$168K
- Allan SooMesa$129K
- Carl FergusonMesa$93K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.